NEWS
Our Latest News
ARCHIMED purchases BioVendor Group, a leading global player in advanced diagnostics
Global private equity healthcare specialist ARCHIMED announces the acquisition of BioVendor Group, a major player in advanced diagnostics, with expertise in immunology, infectious, metabolic, and autoimmune diseases as well as genetics research, expanding ARCHIMED’s numerous investments in the diagnostics industry.
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
January
27,
2025
ARCHIMED earns 5x its investment, selling a majority of Ad-Tech to Tokyo-listed Nihon Kohden
November
26,
2024
368